Ειδήσεις: PHARMACEUTICAL. | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

01/04 14:24 defenseworld.net

Pfizer Inc. $PFE Shares Sold by Frank Rimerman Advisors LLC

Pfizer Frank Rimerman Advisors Horizon Financial Services institutional investors 13F filing share sale

27/03 08:37 defenseworld.net

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Given Consensus Rating of “Moderate Buy” by Analysts

Vertex Pharmaceuticals VRTX Moderate Buy analyst consensus target price Scotiabank

27/03 07:42 defenseworld.net

What is HC Wainwright’s Estimate for ACHV Q1 Earnings?

HC Wainwright Achieve Life Sciences Q1 earnings EPS estimate Buy rating target price

25/03 10:12 defenseworld.net

Insmed (NASDAQ:INSM) Price Target Raised to $213.00 at Bank of America

Insmed price target Bank of America Royal Bank of Canada Citigroup HC Wainwright

23/03 07:44 defenseworld.net

Q3 Earnings Estimate for Novavax Issued By Zacks Research

Novavax Q3 earnings Zacks Research EPS estimate negative ROE net margin

19/03 09:54 defenseworld.net

Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded to “Buy” at Maxim Group

Vertex Pharmaceuticals buy rating Maxim Group Weiss Ratings HC Wainwright UBS Group

19/03 07:16 defenseworld.net

Brokers Offer Predictions for EPRX Q2 Earnings

Eupraxia EPRX HC Wainwright earnings forecast Q2 2026 buy rating

18/03 09:41 defenseworld.net

Ceva, Inc. (NASDAQ:CEVA) Given Average Rating of “Moderate Buy” by Analysts

Ceva Inc.NASDAQ Moderate Buy Analyst Ratings Price Target

18/03 08:21 investing.com

Valneva reports wider loss despite revenue growth

Valneva vaccine earnings loss revenue growth R&D

18/03 08:21 investing.com

Valneva reports wider loss despite revenue growth

Valneva vaccine earnings loss revenue growth R&D

Loading...